{"schema_version":"secwatch.filing_event.v1","accession":"0001681622-24-000058","form_type":"8-K","ticker":"VREX","cik":"0001681622","company_name":"Varex Imaging Corp","filed_at":"2024-05-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.564043+00:00","generated_at":"2026-06-03T00:37:30.036272+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Varex Q2 revenue $206M, down 10% YoY; lowers H2 outlook due to China softness","bullets":["Revenue $206M, down 10% YoY; GAAP EPS $0.03, Non-GAAP EPS $0.16 (down from $0.26).","Medical segment revenue $149M (-15% YoY); Industrial $57M (+6% YoY).","Non-GAAP gross margin 33% flat YoY; operating cash flow $3M.","Q3 guidance: revenue $200-220M, non-GAAP EPS $0.05-$0.25; management lowered H2 expectations.","CEO cited continued softness in China as primary headwind for medical segment."],"urls":{"canonical":"https://secwatch.observer/filing/0001681622-24-000058","json":"https://secwatch.observer/filing/0001681622-24-000058.json","markdown":"https://secwatch.observer/filing/0001681622-24-000058.md","text":"https://secwatch.observer/filing/0001681622-24-000058.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1681622/000168162224000058/0001681622-24-000058-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1681622/000168162224000058/vrex-20240502.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T00:37:30.036272+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3dba300bb6959d0a4d4dda2659bc47e9eaba1f81","claim":"Varex Imaging Corp reported three and six months ended March 29, 2024 (second quarter of fiscal year 2024) results: revenue $206 million, net income GAAP net earnings $0.03 per diluted share; Non-GAAP net earnings $0.16 per diluted share. Guidance lowered.","evidence_excerpt":"May 2, 2024 – Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the second quarter of fiscal year 2024. 2QFY24 Summary • Revenues $206 million • GAAP gross margin 32% | Non-GAAP gross margin* 33% • GAAP operating margin 4% | Non-GAAP operating margin* 6% • GAAP net earnings $0.03 per diluted share | Non-GAAP net","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1681622/000168162224000058/0001681622-24-000058-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three and six months ended March 29, 2024 (second quarter of fiscal year 2024)"},{"label":"Revenue","value":"$206 million"},{"label":"Net income","value":"GAAP net earnings $0.03 per diluted share; Non-GAAP net earnings $0.16 per diluted share"},{"label":"Guidance","value":"lowered"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}